Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

A study (Wyeth-Ayerst Laboratories, 1985) using rat  was available. The approx. LD50 for male was 672.7 mg/kg bw, for female was 336.4 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
April to May 1984
Reliability:
1 (reliable without restriction)
Qualifier:
no guideline followed
Principles of method if other than guideline:
This study used rat (male/female), and the dosage was 3, 10, 50, 200, 400 and 600 mg/kg bw.
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no
Species:
rat
Strain:
other: CRL:CD (SD) BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source:Charles River Breeding Laboratories, Inc., Wilmington, MA 01887
- Age at study initiation:6 to 7 weeks
- Weight at study initiation:110 to 209 grams
- Fasting period before study:Rats were deprived of food overnight prior to, and 1 hour following administration.
- Housing:Metal and wire mesh suspended cages
- Diet (e.g. ad libitum):Purina Rodent Laboratory Chow No. 5001 (Checkers). Food is freely offered at all other times.
- Water (e.g. ad libitum):Tap water in individual bottles. Water is offered ad libitum throughout the study.
- Acclimation period:7 to 8 days
Route of administration:
other: oral gastric intubation
Vehicle:
other: sterile water
Doses:
Dose range testing:
Male: 100, 200, 400, 600, 800, 1000, 1740, 2950 mg/kg
Female: 100, 200, 280, 400, 600 mg/kg
No effect testing: 3, 10 and 50 mg/kg
Dose volume: 5 ml/kg
No. of animals per sex per dose:
3 females and 3 males per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 7 days
- Frequency of observations and weighing:during the first day amd at least daily thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs,gross visceral abnormalities
Sex:
male
Dose descriptor:
LD0
Effect level:
>= 200 - < 400 mg/kg bw
Based on:
test mat.
Sex:
female
Dose descriptor:
LD0
Effect level:
>= 200 - < 280 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
approximate LD50
Effect level:
672.7 mg/kg bw
Based on:
test mat.
95% CL:
>= 327.8 - <= 1 058.8
Sex:
female
Dose descriptor:
approximate LD50
Effect level:
336.4 mg/kg bw
Based on:
test mat.
95% CL:
>= 179.6 - <= 789.2
Mortality:
All deaths occurred from 8 minutes to approximately 4 hours after dosing. Immediate antemortem observations included tonic convulsions, a loss of righting reflex and dyspnea with subsequent respiratory arrest.
Clinical signs:
other: Mydriasis, salivation and evidence of a combination of central nervous system depression, motor incoordination (decreased motor activity, bradypnea, ataxia, tremors), and CNS excitation (tonic convulsions, straub tail). Effects began within 1 minute after
Gross pathology:
From gross visceral examinations, rats that died after doses of 280, 400, 600, 800, 1000, 1740 and 2950 mg/kg: heart activity was present and there were no remarkable abnormalities found.
Rats that were sacrificed 7 days after doses of 3, 10, 50, 100, 200, 280, 400, 600, 800 and 1000 mg/kg: There were no remarkable abnormalities
found.
Interpretation of results:
Toxicity Category IV
Remarks:
Migrated information
Conclusions:
No-Effect dose: 50 mg/kg (male and female)
Lowest dose administered at which death occurred: Male-400 mg/kg; Female-280 mg/kg.
Highest dose administered which was non-lethal: 200 mg/kg (male and female)
Approximate Median Lenthal Doses (95% confidence limits):
Male: 672.7 (327.8-1058.8) mg/kg; Female: 336.4 (179.6-789.2) mg/kg
These results suggest a possible sex-related difference in the lethality of WY-45,030 HCl, with females having greater sensitivity than males.
Executive summary:

An acute oral toxicity study of WY-45,030 HCl showed approx.LD50 to be 672.7 and 336.4 mg/kg for males and females, respectively. And females had greater sensitivity than males.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
336.4 mg/kg bw
Quality of whole database:
acute toxic class method

Additional information

A study (Wyeth-Ayerst Laboratories, 1985) using rat was available. Key study.

The study showed that the approx. LD50 for male was 672.7 mg/kg bw, for female was 336.4 mg/kg bw.


Justification for selection of acute toxicity – oral endpoint
A study using rat was available.

Justification for classification or non-classification

The approx. LD50 for male was 672.7 mg/kg bw, for female was 336.4 mg/kg bw.

Therefore in accordance with Regulation (EC) No. 1272/2008 Table 3.1.1 the substance is classified as Category 4 for the acute toxicity endpoint.

Specific Target Organ Toxicity - Single Exposure There were no remarkable abnormalities. No specific target organ toxicity was observed following single exposure to the substance. Therefore, classification with STOT SE is not assigned.